Skip to content
375/20375/20375/20

Drawing based on the description in the official product monograph. No photo yet.

“375/20 mg tablets are yellow, oval film coated tablets printed '375/20' in black ink on one side”

375/20 pill

Pill with imprint 375/20 is yellow, oval and has been identified as Esomeprazole Magnesium Trihydrate and Naproxen 20 mg / 375 mg. It is used for arthritis. It is supplied by Xediton Pharmaceuticals Inc.

Sold in Canada

Esomeprazole Magnesium Trihydrate and Naproxen 20 mg / 375 mg

Brand
Vimovo
Imprint
375/20
Strength
Esomeprazole Magnesium Trihydrate 20 mg / Naproxen 375 mg
Used for
Arthritis
Color
Yellow
Shape
Oval
Form
Tablet (immediate- and delayed-release)
Manufacturer
Xediton Pharmaceuticals Inc
Drug class
NSAID (pain and inflammation medicine)
Sold in
Canada
DIN
02361701

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Naproxen and Esomeprazole pills and guides

What is Naproxen and Esomeprazole used for?

Naproxen and Esomeprazole is used for arthritis.

Medicine type
NSAID (pain and inflammation medicine); acid reducer (proton pump inhibitor)
Official uses from the US prescribing label

Naproxen and esomeprazole magnesium delayed-release tablets, a combination of naproxen and esomeprazole magnesium, is indicated in adult and adolescent patients 12 years of age and older weighing at least 38 kg, requiring naproxen for symptomatic relief of arthritis and esomeprazole magnesium to decrease the risk for developing naproxen-associated gastric ulcers.

The naproxen component of naproxen and esomeprazole magnesium delayed-release tablet is indicated for relief of signs and symptoms of:

  • osteoarthritis, rheumatoid arthritis and ankylosing spondylitis in adults.
  • juvenile idiopathic arthritis (JIA) in adolescent patients.

The esomeprazole magnesium component of naproxen and esomeprazole magnesium delayed-release tablet is indicated to decrease the risk of developing naproxen-associated gastric ulcers.

Limitations of Use:

  • Do not substitute naproxen and esomeprazole magnesium delayed-release tablets with the single-ingredient products of naproxen and esomeprazole magnesium.
  • Naproxen and esomeprazole magnesium delayed-release tablets are not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.
  • Controlled studies do not extend beyond 6 months.

From the FDA-approved label on DailyMed (published Jul 27, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows 375/20.
  • It is yellow, oval.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as Vimovo modified-release tablet by Xediton Pharmaceuticals Inc.

In Canada: prescription only.

Ingredients

Active: Esomeprazole (Esomeprazole Magnesium Trihydrate), Naproxen

Other pills with imprint 375 20

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Naproxen and Esomeprazole pills